[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $allr Allarity Therapeutics ($ALLR) receives FDA Fast Track designation for Stenoparib, but the stock faces pressure. Analysts predict upside potential, but social media indicates caution. ### About $allr Allarity Therapeutics, Inc. (ALLR) is a biotechnology company focused on developing cancer treatments. ### Insights [#](/topic/$allr/insights) - $allr mentions hit XXX which is XXX% higher than it's daily average. - $allr creators hit XXX which is XXX% higher than it's daily average. - $allr posts created is up XXXXX% from the previous week. ### Engagements: XXXXXX [#](/topic/$allr/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$allr/time-series/interactions.tsv) **Current Value**: XXXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXX -XX% **1 Month**: XXXXXX -XX% **1-Year High**: XXXXXXX on 2025-08-26 **1-Year Low**: XXX on 2025-10-05 | Social Network | X | Reddit | | -------------- | - | ------ | | Engagements | XXXXXX | XX | ### Mentions: XXX [#](/topic/$allr/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$allr/time-series/posts_active.tsv) **Current Value**: XXX **Daily Average**: XX **1 Month**: XX -XX% **1-Year High**: XXX on 2025-08-27 **1-Year Low**: XX on 2025-10-12 | Social Network | X | Reddit | | -------------- | - | ------ | | Mentions | XXX | X | ### Creators: XXX [#](/topic/$allr/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$allr/time-series/contributors_active.tsv) XXX unique social accounts have posts mentioning $allr in the last XX hours which is up XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **1-Year High**: XXX on 2025-08-27 **1-Year Low**: X on 2025-10-12 The most influential creators that mention $allr in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@WTec78](/creator/twitter/WTec78) | X | XXX | XX | XXXXX | | [@Ceazar_Black](/creator/twitter/Ceazar_Black) | X | XXX | XX | XXXXX | | [@biotech_cash](/creator/twitter/biotech_cash) | X | XXX | X | XXX | | [@Dr_Giggles4u](/creator/twitter/Dr_Giggles4u) | X | XXX | X | XXX | | [@dWnedwlIwDh6dja](/creator/twitter/dWnedwlIwDh6dja) | X | XXX | X | XXX | | [@ThomasRGraves](/creator/twitter/ThomasRGraves) | X | XXX | XX | XXX | | [@CuLKN42](/creator/twitter/CuLKN42) | X | XXX | X | XXX | | [@nyles_barnett](/creator/twitter/nyles_barnett) | X | XXX | X | XXX | | [@BiotechXGuru](/creator/twitter/BiotechXGuru) | X | XXX | XX | XXX | | [@Philip__Went](/creator/twitter/Philip__Went) | XX | XXXXX | X | XXX | [View More](/list/creators/$allr/100) ### Sentiment: XX% [#](/topic/$allr/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$allr/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XX% -X% **1 Month**: XX% no change **1-Year High**: XXX% on 2025-04-27 **1-Year Low**: XX% on 2025-09-14 **Most Supportive Themes** - **FDA Fast Track Designation & Clinical Progress:** (40%) Positive sentiment around Allarity Therapeutics ($ALLR) receiving FDA Fast Track designation for Stenoparib in advanced ovarian cancer. - **Potential for Significant Upside:** (30%) Bullish sentiment suggesting $ALLR has the potential for significant gains. - **Positive Financial Outlook:** (15%) Mentions of positive financial aspects, such as management buybacks and strategic business alternatives. **Most Critical Themes** - **Fragile Structure and Pressure:** (15%) Some posts indicate that the stock is under pressure. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXX | XX% | XXX | X% | | Reddit | X | X% | XX | X% | X | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXX | XX% | XXX | X% | **Top assets mentioned** In the posts about $allr in the last XX hours [Open Custody Protocol (OPEN)](/topic/$open) [Novo-Nordisk (NVO)](/topic/$nvo) [Dun & Bradstreet Holdings, Inc. (DNB)](/topic/$dnb) [Intel Corporation (INTC)](/topic/$intc) [SPDR S&P XXX ETF Trust (SPY)](/topic/$spy) [Johnson & Johnson (JNJ)](/topic/johnson-johnson) [Johnson & Johnson (JNJ)](/topic/$jnj) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Zebec Network (ZBCN)](/topic/zebec-network) [MATH (MATH)](/topic/$math) **Top topics mentioned** In the posts about $allr in the last XX hours [momentum](/topic/momentum), [stocks](/topic/stocks), [targets](/topic/targets), [regulatory](/topic/regulatory), [$sprb](/topic/$sprb), [combo](/topic/combo), [about to](/topic/about-to), [signals](/topic/signals), [catalyst](/topic/catalyst), [fda](/topic/fda), [dual](/topic/dual), [ip](/topic/ip), [upside](/topic/upside), [market cap](/topic/market-cap), [$25m](/topic/$25m), [investment](/topic/investment), [runner](/topic/runner), [click the](/topic/click-the), [indiana](/topic/indiana), [trading strategy](/topic/trading-strategy), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [longterm](/topic/longterm), [spikes](/topic/spikes), [os](/topic/os), [confirms](/topic/confirms), [stocks technology](/topic/stocks-technology), [$404k](/topic/$404k), [money](/topic/money), [$iiil](/topic/$iiil), [$1851k](/topic/$1851k), [$224k](/topic/$224k), [sentiment](/topic/sentiment), [stocks healthcare](/topic/stocks-healthcare), [$alec](/topic/$alec), [$algs](/topic/$algs), [$allk](/topic/$allk), [$allo](/topic/$allo), [$149k](/topic/$149k), [robin](/topic/robin), [mkt cap](/topic/mkt-cap), [loading](/topic/loading), [breakthrough](/topic/breakthrough), [$00272m](/topic/$00272m), [surge](/topic/surge), [spotlight](/topic/spotlight), [$278k](/topic/$278k), [$mrkr](/topic/$mrkr), [$open](/topic/$open), [approved](/topic/approved), [$472m](/topic/$472m), [eu](/topic/eu), [united states dollar](/topic/united-states-dollar), [protocol](/topic/protocol), [$205m](/topic/$205m), [$27m](/topic/$27m), [london](/topic/london), [coins defi](/topic/coins-defi), [coins solana ecosystem](/topic/coins-solana-ecosystem), [$4722m](/topic/$4722m), [unlock](/topic/unlock), [faster](/topic/faster), [deeper](/topic/deeper), [all the](/topic/all-the), [$nvo](/topic/$nvo), [thesis](/topic/thesis), [imo](/topic/imo), [australia](/topic/australia), [$10b](/topic/$10b), [mover](/topic/mover), [$ipsc](/topic/$ipsc), [$glto](/topic/$glto), [$avtx](/topic/$avtx), [$0059m](/topic/$0059m), [$025m](/topic/$025m), [nancy](/topic/nancy), [victor](/topic/victor), [hasan](/topic/hasan), [nasdaq](/topic/nasdaq), [$xair](/topic/$xair), [magnus](/topic/magnus), [$1b](/topic/$1b), [25m](/topic/25m), [shah](/topic/shah), [stack](/topic/stack), [roadmap](/topic/roadmap), [marsh](/topic/marsh), [drugs](/topic/drugs), [benjamin](/topic/benjamin), [$871k](/topic/$871k), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$178m](/topic/$178m), [$hkpd](/topic/$hkpd), [micro](/topic/micro), [$pavs](/topic/$pavs), [$bivi](/topic/$bivi), [$uavs](/topic/$uavs), [$prpo](/topic/$prpo), [mano](/topic/mano), [$ixhl](/topic/$ixhl), [$dnb](/topic/$dnb) ### Top Social Posts [#](/topic/$allr/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "$ALLR Q2 Update Confirms Cash Strength 🚀🚀🚀 With $17.8M in cash and multiple trials advancing Allarity is positioned to accelerate oncology R&D momentum. 👉 X stocks heating upjoin the group to see the list 🔗" [X Link](https://x.com/turneraudrey40/status/1979002281631568089) [@turneraudrey40](/creator/x/turneraudrey40) 2025-10-17T01:51Z XX followers, XXX engagements "$ALLR Expands DRP Licensing Reach 🚀🚀🚀 Allarity signed a new partnership to extend its AI-powered drug response predictor into Europes cancer research market. 👉 Track turning-point stocks with daily trade signals in the group. 🔗" [X Link](https://x.com/LaurenKing0718/status/1979002251977900391) [@LaurenKing0718](/creator/x/LaurenKing0718) 2025-10-17T01:51Z XXX followers, XX engagements "$ALLR Clinical Data Surprise 🚀🚀🚀 Phase X results show some patients exceeding XX months survivalclear signal of strong efficacy potential for Stenoparib. 👉 Missed the last XXX% runner Dont miss the nextjoin now. 🔗" [X Link](https://x.com/neonheartrock/status/1979002230280749197) [@neonheartrock](/creator/x/neonheartrock) 2025-10-17T01:51Z XXX followers, XX engagements "$ALLR @AllarityTx clinically significant endpoint to approve BTD Breakthrough Therapy Significantly improved safety profile compared to available therapy (e.g. less dose-limiting toxicity for an oncology agent) with evidence of similar efficacy" [X Link](https://x.com/WTec78/status/1978990409507308019) [@WTec78](/creator/x/WTec78) 2025-10-17T01:04Z XXX followers, 1003 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$allr
Allarity Therapeutics ($ALLR) receives FDA Fast Track designation for Stenoparib, but the stock faces pressure. Analysts predict upside potential, but social media indicates caution.
About $allr
Allarity Therapeutics, Inc. (ALLR) is a biotechnology company focused on developing cancer treatments.
Insights #
- $allr mentions hit XXX which is XXX% higher than it's daily average.
- $allr creators hit XXX which is XXX% higher than it's daily average.
- $allr posts created is up XXXXX% from the previous week.
Engagements: XXXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-08-26
1-Year Low: XXX on 2025-10-05
| Social Network | X | |
|---|---|---|
| Engagements | XXXXXX | XX |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-08-27
1-Year Low: XX on 2025-10-12
| Social Network | X | |
|---|---|---|
| Mentions | XXX | X |
Creators: XXX #
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning $allr in the last XX hours which is up XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
1-Year High: XXX on 2025-08-27
1-Year Low: X on 2025-10-12
The most influential creators that mention $allr in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @WTec78 | X | XXX | XX | XXXXX |
| @Ceazar_Black | X | XXX | XX | XXXXX |
| @biotech_cash | X | XXX | X | XXX |
| @Dr_Giggles4u | X | XXX | X | XXX |
| @dWnedwlIwDh6dja | X | XXX | X | XXX |
| @ThomasRGraves | X | XXX | XX | XXX |
| @CuLKN42 | X | XXX | X | XXX |
| @nyles_barnett | X | XXX | X | XXX |
| @BiotechXGuru | X | XXX | XX | XXX |
| @Philip__Went | XX | XXXXX | X | XXX |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% -X%
1 Month: XX% no change
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-09-14
Most Supportive Themes
- FDA Fast Track Designation & Clinical Progress: (40%) Positive sentiment around Allarity Therapeutics ($ALLR) receiving FDA Fast Track designation for Stenoparib in advanced ovarian cancer.
- Potential for Significant Upside: (30%) Bullish sentiment suggesting $ALLR has the potential for significant gains.
- Positive Financial Outlook: (15%) Mentions of positive financial aspects, such as management buybacks and strategic business alternatives.
Most Critical Themes
- Fragile Structure and Pressure: (15%) Some posts indicate that the stock is under pressure.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXXXX | XX% | XXXXX | XX% | XXX | X% |
| X | X% | XX | X% | X | X% | |
| Total | XXXXX | XX% | XXXXX | XX% | XXX | X% |
Top assets mentioned In the posts about $allr in the last XX hours
Open Custody Protocol (OPEN) Novo-Nordisk (NVO) Dun & Bradstreet Holdings, Inc. (DNB) Intel Corporation (INTC) SPDR S&P XXX ETF Trust (SPY) Johnson & Johnson (JNJ) Johnson & Johnson (JNJ) Protagonist Therapeutics, Inc (PTGX) Zebec Network (ZBCN) MATH (MATH)
Top topics mentioned In the posts about $allr in the last XX hours
momentum, stocks, targets, regulatory, $sprb, combo, about to, signals, catalyst, fda, dual, ip, upside, market cap, $25m, investment, runner, click the, indiana, trading strategy, stocks bitcoin treasuries, longterm, spikes, os, confirms, stocks technology, $404k, money, $iiil, $1851k, $224k, sentiment, stocks healthcare, $alec, $algs, $allk, $allo, $149k, robin, mkt cap, loading, breakthrough, $00272m, surge, spotlight, $278k, $mrkr, $open, approved, $472m, eu, united states dollar, protocol, $205m, $27m, london, coins defi, coins solana ecosystem, $4722m, unlock, faster, deeper, all the, $nvo, thesis, imo, australia, $10b, mover, $ipsc, $glto, $avtx, $0059m, $025m, nancy, victor, hasan, nasdaq, $xair, magnus, $1b, 25m, shah, stack, roadmap, marsh, drugs, benjamin, $871k, stocks crypto treasuries, $178m, $hkpd, micro, $pavs, $bivi, $uavs, $prpo, mano, $ixhl, $dnb
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ALLR Q2 Update Confirms Cash Strength 🚀🚀🚀 With $17.8M in cash and multiple trials advancing Allarity is positioned to accelerate oncology R&D momentum. 👉 X stocks heating upjoin the group to see the list 🔗"
X Link @turneraudrey40 2025-10-17T01:51Z XX followers, XXX engagements
"$ALLR Expands DRP Licensing Reach 🚀🚀🚀 Allarity signed a new partnership to extend its AI-powered drug response predictor into Europes cancer research market. 👉 Track turning-point stocks with daily trade signals in the group. 🔗"
X Link @LaurenKing0718 2025-10-17T01:51Z XXX followers, XX engagements
"$ALLR Clinical Data Surprise 🚀🚀🚀 Phase X results show some patients exceeding XX months survivalclear signal of strong efficacy potential for Stenoparib. 👉 Missed the last XXX% runner Dont miss the nextjoin now. 🔗"
X Link @neonheartrock 2025-10-17T01:51Z XXX followers, XX engagements
"$ALLR @AllarityTx clinically significant endpoint to approve BTD Breakthrough Therapy Significantly improved safety profile compared to available therapy (e.g. less dose-limiting toxicity for an oncology agent) with evidence of similar efficacy"
X Link @WTec78 2025-10-17T01:04Z XXX followers, 1003 engagements